Luna Bioscience, Inc.

Westport, CT Luna Bioscience, Inc.

UEI
HXZHX26PAUW5
CAGE
Not on record
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
39 Stony Brook Rd, Westport, CT 06880, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

About Luna Bioscience, Inc.

Luna Bioscience, Inc. is a woman-owned small business based in Westport, Connecticut, that specializes in the development of diagnostic assays and vaccines for infectious diseases. The company focuses on advancing point-of-care and laboratory-based diagnostic solutions, particularly for emerging and neglected tropical diseases. Luna Bioscience has established itself as a recipient of federal grant funding from the National Institute of Allergy and Infectious Diseases (NIAID), positioning itself as a biotech innovator addressing critical gaps in clinical diagnostics and preventive medicine.

Luna Bioscience has received three federal Project Grants under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) from NIAID, totaling significant investment in leptospirosis diagnostic and vaccine development. The company's most recent award, a $300,435 Project Grant granted on September 24, 2025, supports the development of solid-phase antibody-detection assays using recombinant virulence-modifying protein (VMP)-based ELISA tests for the rapid, point-of-care diagnosis of acute leptospirosis. An earlier Project Grant awarded on May 7, 2024, focused on developing antigen-detection assays targeting leptospiral VM proteins and other pathogenic markers in body fluids to enable rapid diagnostic capability. Additionally, Luna Bioscience received a Project Grant dated July 1, 2023, for leptospirosis vaccine development, which involved creating recombinant VM protein immunogens to develop the first human leptospirosis vaccine. These grants demonstrate Luna Bioscience's core competency in translating basic scientific discoveries into clinically actionable diagnostic and preventive products for a globally important infectious disease affecting military personnel, travelers, and tropical populations, with work completion timelines extending through August 2027.

Quick answers

What is Luna Bioscience, Inc.'s UEI?

Luna Bioscience, Inc.'s Unique Entity ID (UEI) in SAM.gov is HXZHX26PAUW5.

Where is Luna Bioscience, Inc. located?

Luna Bioscience, Inc.'s physical address in SAM.gov is 39 Stony Brook Rd, Westport, CT 06880, USA.

Is Luna Bioscience, Inc. registered in SAM.gov?

Yes. Luna Bioscience, Inc.'s SAM.gov registration is active through January 8, 2027.

What is Luna Bioscience, Inc.'s most recent federal award?

Luna Bioscience, Inc.'s most recent federal grant award is Development of surrogate biomarkers for supporting clinical trials of human leptospirosis vaccines - luna bioscience,… (R41AI197598), from National Institute of Allergy and Infectious Diseases, on July 14, 2026.

On GovTribe

See Luna Bioscience, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors